Why Relevium is diversifying its product portfolio

Market One
6 min readJul 9, 2020
Relevium’s CleanCare advanced formula uses 70 per cent alcohol to sterilize your hands and Vitamin E to soothe your hands.

• The 2020 market size value for hand sanitizer is expected to reach USD$3.3 billion

• Relevium’s new CleanCare Sanitizer line reached $250,000 in pre-sales in the first six days

• The company continues to drive the wellness market with innovative air filtration system

2020 hasn’t exactly been the year anyone was expecting. No one anticipated the demand for rubber gloves to skyrocket or that couture face masks would hit the market in one of the more unexpected fashion trends in recent memory.

However, now that we’ve adapted to this new reality, anticipating how consumers’ buying habits will evolve is becoming less elusive. The quest for peace of mind is now a driving force for many buyers, and this thought process is demonstrated with every store displaying a “1 per person” sign above certain sanitary products.

“We knew this wasn’t just a trend, and that it would continue to grow.”

— Aurelio Useche, CEO, Relevium Technologies Inc.

Specifically, demand for disinfection solutions, in particular hand sanitizers has created a fervour among consumers, ballooning the product’s market valuation to USD$3.3 billion for 2020, according to Grand View Research.

Unfortunately, despite this item making its way onto the “essentials” shopping list, many consumers still see hand sanitizer brands as interchangeable. This blurred space in consumers’ minds has created an opportunity for a new market to emerge in the branded sanitizer segment.

Shoppers have now begun to pursue higher-quality sanitary products beyond what’s available at the corner drug store, similar to how they see the various qualities of soap available.

Innovative organizations are noticing this shifting perception of sanitizer and are aptly catering to demand.

Canadian brand seizes new disinfection and sanitizer market potential

Market pundits need look no further for proof of this development than the portfolio of

Relevium Technologies Inc. (TSXV: RLV | OTC: RLLVF | FSE: 6BX). Based out of Quebec, and founded in 2012, Relevium focuses on the acquisition of e-brands, primarily within nutraceuticals, sports nutrition and nutri-cosmeceuticals.

Relevium’s product is made in FDA registered and approved facilities in the U.S.

Earlier this year, the company released CleanCare, a premium hand sanitizer developed through one of its key brands, Bioganix. The release impressively hit $250,000 in pre-sales in its first six days on the market.

What makes the CleanCare line different is that it works as both a sanitizer and moisturizer, using a formula blend of Vitamin E and top-grade medical alcohol. The latter point is in contrast to most brands typically using food-grade alcohol that can leave a “Tequila-like smell on the hand,” according to the company’s CEO, Aurelio Useche. Prior to the COVID-19 pandemic, Relevium had already been exploring a new standard for hand sanitizers as the market was growing even then.

The company’s anticipation of this shift is what Useche says steered them in the right direction.

He notes, “We noticed companies like Bath and Bodyworks doing about $100 million annually just in this space. We knew this wasn’t just a trend, and that it would continue to grow.”

This pivot to adhere to changes was led by the company’s subsidiary, BGX E-Health LLC, which owns the Bioganix brand. Specializing in nutritional supplements, Bioganix offers health and immune-boosting products affordably and transparently. Their customer-first product standards were the catalyst for the development of CleanCare.

Useche explains, “The combination of the unusually high demand created by COVID-19 and the scarcity of supply in the market created long lead times for some of the critical components, including alcohol and packaging supplies. These market conditions led to the appearance of cheap, non-compliant imported products, some of which have been recalled.”

He adds, “We are extremely pleased to be able to provide to the market and begin the successful delivery of a premium and compliant product made in the U.S. and Canada.”

Bacteria prevention by wiping high-traffic surfaces, such as door handles.

Bioganix’s focus on quality and trust has already proven to be a successful formula. In March of this year, Relevium’s subsidiary, BGX E-Health, began exporting products overseas including Saudi Arabia, where the company is supplying $1 million worth of generic formulations.

Useche notes, “This first shipment to our international customer presents a new milestone for the company as it embarks on expanding with global partners around the world for generic formulations and nutraceuticals.”

“Our manufacturing partnerships have enabled us to expand our footprint into international markets such as Saudi Arabia and diversify our global sales channels, which stem mainly through online sales.”

Moreover, on June 19, 2020, the company announced that it has expanded its CleanCare product line as it prepares to address the increased government and institutional demand for disinfection supplies in preparation for a potential second wave of COVID-19.

According to the company’s press release, NATO nations have agreed to stockpile medical equipment and essential supplies to prepare for an anticipated second wave of COVID-19. Moreover, the NATO Defence Ministers have asked member nations to contribute to an emergency fund to buy even more supplies as the alliance braces for the second wave.

Regarding this development, Useche says, “The company is preparing a B2B and B2C strategy to bring CleanCare Air Purifiers, alcohol-free formulas and differentiating technology to market via national retailers, institutional wholesalers and direct-to-consumers through specialized e-commerce partners.”

Release of personal air filtration system will combat airborne viruses

Despite the promising deals already made in the health and wellness space, Relevium and Bioganix aren’t content to rest on their laurels. In April, Relevium announced that it would launch a photocatalytic UV air filtration system for residential and commercial use. Joining the Bioganix CleanCare line of personal health products, the system contains UV and photocatalytic technology with capabilities of particulate and gas filtration.

The system can eliminate airborne pollutants, including viruses and bacteria, a growing concern for the seasoned pandemic consumers. Scheduled to hit the market in the fall of 2020, the air filtration system has significant application potential for retirement homes and community centres, as authorities continue to monitor areas with a high risk of contamination.

Washing hands with soap and hot water at home is a great way to get rid of bacteria.

What’s next?

With the launch of this system and its continued innovation, Relevium is securing its name alongside other heavy hitters in the health and wellness sector. Further evidence of Relevium’s rise are developments that include their increase of purchase orders for hand sanitizer through expansion into new markets and the introduction of new products in the health and wellness space.

Despite 2020’s continued efforts to keep us on our toes, one thing is for sure: Relevium is about to have a very promising year.

Learn more about the company’s development and growth plans by visiting their website here.

Follow Relevium on social media.






Market One

Canada’s leading marketing agency for public companies.